Subsequent Events	6 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events During July 2026, the Company announced it has entered into definitive agreements to sell its controlling interest in two hospitals for total consideration of approximately $795 million, which includes amounts related to Surgery Partners proportionate ownership interest in long-term debt. Total cash proceeds to the Company are subject to customary purchase price adjustments, including adjustments for indebtedness, working capital, transaction expenses, and other closing items. Completion of the transaction is subject to customary closing conditions, including the execution of binding Securities Purchase Agreements between the Company and the buyer following requisite physician member and physician governing board approvals. Accordingly, the Company is unable to provide a reasonable estimate of final net cash proceeds at this time.

Subsequent Events

6 Months Ended

Jun. 30, 2026

During July 2026, the Company announced it has entered into definitive agreements to sell its controlling interest in two hospitals for total consideration of approximately $795 million, which includes amounts related to Surgery Partners proportionate ownership interest in long-term debt. Total cash proceeds to the Company are subject to customary purchase price adjustments, including adjustments for indebtedness, working capital, transaction expenses, and other closing items. Completion of the transaction is subject to customary closing conditions, including the execution of binding Securities Purchase Agreements between the Company and the buyer following requisite physician member and physician governing board approvals. Accordingly, the Company is unable to provide a reasonable estimate of final net cash proceeds at this time.